Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
Is a |
Product containing amylase (medicinal product) |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
Is a |
Product containing triacylglycerol lipase (medicinal product) |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
Is a |
Protease-containing product |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amylase (substance) |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lipase preparation |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with protease mechanism of action |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
Is a |
amylase + lipase + protease |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lipase |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
Has manufactured dose form |
Oral powder |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Triacylglycerol lipase |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Endopeptidase (substance) |
false |
Inferred relationship |
Some |
|
|
amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|